| PubMed | Title | Journal | Year | Linked by |
|---|
| PMID 41690324 | Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trial. | The lancet. HIV | 2026 | cited by trial NCT05515042 |
| PMID 42061096 | A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector-based vaccines. | EBioMedicine | 2026 | name in abstract: Ad26.COV2.S |
| PMID 42085933 | Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection. | EBioMedicine | 2026 | name in title: Ad26.COV2.S |
| PMID 42951458 | Association Between Acute Vulvar Ulcers and Gene-Based COVID-19 Vaccines. | Taiwanese journal of obstetrics & gynecology | 2026 | name in abstract: Ad26.COV2.S |
| PMID 39817585 | Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia. | Journal of medical virology | 2025 | name in abstract: Ad26.COV2.S |
| PMID 39866854 | Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial. | EClinicalMedicine | 2025 | cited by trial NCT05091307 |
| PMID 39868766 | Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial. | Human vaccines & immunotherapeutics | 2025 | cited by trial NCT05007080 |
| PMID 40014936 | Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study. | Journal of infection and public health | 2025 | name in title: Jcovden |
| PMID 40068393 | Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron. | Vaccine | 2025 | cited by trial NCT05697705 |
| PMID 40298376 | Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. | The Journal of infectious diseases | 2025 | cited by trial NCT04889209 |
| PMID 40425703 | Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database. | Scientific reports | 2025 | name in abstract: Jcovden |
| PMID 40663029 | Responses of Kidney Transplant Recipients to Vaccination and Boosting. | Mayo Clinic proceedings | 2025 | cited by trial NCT05220397 |
| PMID 40694514 | Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2025 | cited by trial NCT04998240 |
| PMID 40730836 | Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial. | Scientific reports | 2025 | name in abstract: Ad26.COV2.S |
| PMID 40808283 | Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy. | Human vaccines & immunotherapeutics | 2025 | cited by trial NCT04765384 |
| PMID 41239286 | Long-term trends in reporting of cardiac adverse drug reactions to COVID-19 vaccines - an exploratory analysis of the EudraVigilance database. | BMC infectious diseases | 2025 | name in abstract: Jcovden |
| PMID 41289027 | Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial. | JCI insight | 2025 | cited by trial NCT05000216 |
| PMID 41378554 | Clot twist - D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde | 2025 | name in title: Ad26.COV2.S |
| PMID 41402886 | A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial. | Trials | 2025 | name in title: Ad26.COV2.S |
| PMID 37992183 | The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review. | The Journal of infectious diseases | 2024 | cited by trial NCT04889209 |
| PMID 38278629 | Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. | Vaccine | 2024 | cited by trial NCT05148845 |
| PMID 38467646 | Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. | Nature communications | 2024 | cited by trial NCT04505722 |
| PMID 38705804 | Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study. | Vaccine | 2024 | cited by trial NCT04535453 |
| PMID 38744598 | Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial. | Vaccine | 2024 | cited by trial NCT05109559 |
| PMID 38762522 | Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters. | Nature communications | 2024 | name in abstract: Ad26.COV2.S |
| PMID 38902860 | Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial. | Transplantation | 2024 | cited by trial NCT05030974 |
| PMID 38918103 | Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial. | Vaccine | 2024 | cited by trial NCT04999111 |
| PMID 38958922 | Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac. | Frontiers of medicine | 2024 | name in abstract: Ad26.COV2.S |
| PMID 39111095 | Optic neuritis following COVID-19 vaccination: Case series and review of the literature. | Journal francais d'ophtalmologie | 2024 | name in abstract: Ad26.COV2.S |
| PMID 39121698 | Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk. | Vaccine | 2024 | cited by trial NCT04999111 |
| PMID 39225478 | Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. | The Journal of infectious diseases | 2024 | cited by trial NCT04505722 |
| PMID 39272117 | Patient engagement as a collaborative process in a large Dutch COVID-19 vaccination study (RECOVAC) - insight into the contribution of patient engagement and learnings for the future. | Research involvement and engagement | 2024 | cited by trial NCT05030974 |
| PMID 39470514 | Polymyalgia rheumatica following COVID-19 vaccination: Case series of 3 patients and literature review on polymyalgia rheumatica induced by various vaccines. | Medicine | 2024 | name in abstract: Ad26.COV2.S |
| PMID 39532861 | Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. | Nature communications | 2024 | cited by trial NCT04505722 |
| PMID 39697294 | An observational post-authorization study to assess the effectiveness of a single dose Ad26.COV2.S for the prevention of COVID-19 using real-world data. | Frontiers in public health | 2024 | name in title: Ad26.COV2.S |
| PMID 35605819 | Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease. | Gastroenterologia y hepatologia | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36057889 | Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan. | International journal of hematology | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36211224 | Systemic lupus erythematosus myocarditis after COVID-19 vaccination. | Reumatologia clinica | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36354032 | Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial. | The Lancet. Infectious diseases | 2023 | cited by trial NCT05030974 |
| PMID 36398559 | Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series. | British journal of clinical pharmacology | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36458888 | An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline. | Clinical toxicology (Philadelphia, Pa.) | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36466142 | Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbidities. | Allergo journal international | 2023 | name in title: Ad26.COV2.S |
| PMID 36539057 | The type of SARS-CoV-2 vaccine does not affect ovarian function in assisted reproduction cycle. | Fertility and sterility | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36643729 | Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report. | Bulletin of the National Research Centre | 2023 | name in title: Ad26.COV2.S |
| PMID 36694608 | Cerebral venous sinus thrombosis after COVID-19 vaccination: a case report and literature review. | Oxford medical case reports | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36732164 | Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan. | Vaccine | 2023 | cited by trial NCT04509947 |
| PMID 36739118 | Systemic lupus erythematosus myocarditis after COVID-19 vaccination. | Reumatologia clinica | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36741657 | A Case of Vaccine-Induced Thrombocytopenic Thrombosis Manifesting as Cerebral Venous Thrombosis and Intracerebral Bleed. | Cureus | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36817454 | Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion. | Frontiers in immunology | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36828523 | Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19. | Tropical medicine and infectious disease | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36852853 | Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination. | Journal of Korean medical science | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36928720 | COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report. | Immunologic research | 2023 | name in abstract: Ad26.COV2.S |
| PMID 36975207 | Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial. | eLife | 2023 | name in abstract: Ad26.COV2.S |
| PMID 37038643 | COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey. | Journal of Korean medical science | 2023 | name in abstract: Ad26.COV2.S |
| PMID 37063238 | Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study). | BMJ medicine | 2023 | cited by trial NCT04838795 |
| PMID 37085049 | Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. | The Journal of infection | 2023 | name in abstract: Ad26.COV2.S |
| PMID 37087559 | Kidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocytopenia. | The American journal of case reports | 2023 | name in title: Ad26.COV2.S |
| PMID 37088096 | Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial. | The Lancet. Infectious diseases | 2023 | name in abstract: Ad26.COV2.S |
| PMID 37091963 | A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients. | Transplant international : official journal of the European Society for Organ Transplantation | 2023 | name in title: JNJ-78436735 |
| PMID 37195456 | Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial. | Journal of patient-reported outcomes | 2023 | name in abstract: Ad26.COV2.S |
| PMID 37344265 | Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial. | Vaccine | 2023 | cited by trial NCT05109559 |
| PMID 37385888 | Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. | Vaccine | 2023 | cited by trial NCT04505722 |
| PMID 37433788 | Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. | NPJ vaccines | 2023 | cited by trial NCT04889209 |
| PMID 37652823 | Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults. | Vaccine | 2023 | name in abstract: Ad26.COV2.S |
| PMID 34254358 | Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective. | Journal of clinical pharmacy and therapeutics | 2022 | name in title: Ad26.COV2.S |
| PMID 34269723 | DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination. | Clinical nuclear medicine | 2022 | name in abstract: COVID-19 Vaccine Janssen |
| PMID 34420869 | Temporal Association Between the COVID-19 Ad26.COV2.S Vaccine and Acute Myocarditis: A Case Report and Literature Review. | Cardiovascular revascularization medicine : including molecular interventions | 2022 | name in title: Ad26.COV2.S |
| PMID 34614491 | Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. | Acta haematologica | 2022 | name in abstract: Ad26.COV2.S |
| PMID 34626338 | Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US. | Infection | 2022 | name in title: Ad26.COV2.S |
| PMID 34672380 | Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). | Journal of clinical apheresis | 2022 | name in abstract: Ad26.COV2.S |
| PMID 34872162 | Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response. | British journal of haematology | 2022 | name in title: Ad26.COV2.S |
| PMID 34900001 | Optic neuritis after COVID-19 vaccine application. | Clinical & experimental neuroimmunology | 2022 | name in abstract: Ad26.COV2.S |
| PMID 34928302 | Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial. | JAMA internal medicine | 2022 | name in abstract: Ad26COVS1 |
| PMID 34986404 | Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022 | name in title: Ad26.COV2.S |
| PMID 35045226 | Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming. | The New England journal of medicine | 2022 | name in title: Ad26.COV2.S |
| PMID 35049005 | Acute embolisms in multiple arterial districts following Ad26.COV2-S vaccine. | European review for medical and pharmacological sciences | 2022 | name in title: Ad26.COV2.S |
| PMID 35071987 | Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report. | SN comprehensive clinical medicine | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35073571 | Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study. | Blood advances | 2022 | cited by trial NCT05007860 |
| PMID 35074136 | Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. | Lancet (London, England) | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35081293 | Homologous and Heterologous Covid-19 Booster Vaccinations. | The New England journal of medicine | 2022 | cited by trial NCT04889209 |
| PMID 35096528 | Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination. | IDCases | 2022 | name in title: Ad26.COV2.S |
| PMID 35113987 | Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient. | Blood | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35135671 | A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson). | Therapie | 2022 | name in title: Ad26.COV2.S |
| PMID 35139271 | Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. | The New England journal of medicine | 2022 | cited by trial NCT04505722 |
| PMID 35144972 | Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. | Clinical journal of the American Society of Nephrology : CJASN | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35157644 | Guillain-Barré Syndrome After Ad26.COV2.S Vaccination. | The American journal of case reports | 2022 | name in title: Ad26.COV2.S |
| PMID 35189775 | A case of myocarditis following ChAdOx1 nCov-19 vaccination. | Acta cardiologica | 2022 | name in abstract: Ad26COVS1 |
| PMID 35215900 | Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester. | Viruses | 2022 | name in title: Ad26.COV2.S |
| PMID 35217969 | Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2022 | name in title: Ad26.COV2.S |
| PMID 35276381 | Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study. | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022 | name in abstract: JNJ-78436735 |
| PMID 35277439 | Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study. | Neurology | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35305740 | Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. | Lancet (London, England) | 2022 | cited by trial NCT04838795 |
| PMID 35331228 | Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases. | BMC oral health | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35371813 | Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report. | Cureus | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35405168 | Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. | The Journal of infection | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35419151 | Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject. | The Neurohospitalist | 2022 | name in title: Ad26.COV2.S |
| PMID 35429381 | Impact of Preexisting Anti-Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine. | The Journal of infectious diseases | 2022 | name in title: Ad26.COV2.S |
| PMID 35444866 | Not All That Is Droopy Post Ad26.COV2.S (JNJ) Vaccine Is Bell's Palsy: A Rare Case of Isolated Dorsal Pontine Stroke Causing Ipsilateral Complete Hemi-Facial Palsy. | Cureus | 2022 | name in title: Ad26.COV2.S |
| PMID 35446353 | Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant. | JAMA oncology | 2022 | name in abstract: JNJ-78436735 |
| PMID 35449682 | Vaccine-Induced Thrombotic Thrombocytopenia: A Case Report. | Cureus | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35494984 | Vaccine-Induced Thrombotic Thrombocytopenia: A Case of Splanchnic Veins Thrombosis. | Cureus | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35512656 | Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature. | Cerebrovascular diseases (Basel, Switzerland) | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35528839 | Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review. | Frontiers in cardiovascular medicine | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35535430 | Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis. | Platelets | 2022 | name in title: Ad26.COV2.S |
| PMID 35589271 | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination. | BMJ case reports | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35599706 | Vaccine-induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report. | Research and practice in thrombosis and haemostasis | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35620997 | Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2022 | name in abstract: COVID-19 Vaccine Janssen |
| PMID 35667914 | Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. | Vaccine | 2022 | cited by trial NCT04436276 |
| PMID 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022 | name in title: Ad26.COV2.S |
| PMID 35714462 | Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35727802 | Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. | PLoS medicine | 2022 | cited by trial NCT04838795 |
| PMID 35751559 | Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review. | Acta dermatovenerologica Alpina, Pannonica, et Adriatica | 2022 | name in title: Ad26.COV2.S |
| PMID 35798000 | Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. | Cell reports. Medicine | 2022 | cited by trial NCT04889209 |
| PMID 35812459 | Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients. | Frontiers in immunology | 2022 | name in title: Ad26COVS1 |
| PMID 35815297 | Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine. | Cureus | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35884709 | Tolosa-Hunt Syndrome and Hemorrhagic Encephalitis Presenting in a Patient after COVID-19 Vaccination Followed by COVID-19 Infection. | Brain sciences | 2022 | name in abstract: Ad26.COV2.S |
| PMID 35911081 | Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine. | Case reports in hematology | 2022 | name in title: Ad26.COV2.S |
| PMID 36054163 | Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database. | Annals of neurology | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36113538 | Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. | The Lancet. Infectious diseases | 2022 | cited by trial NCT04614948 |
| PMID 36121258 | Longitudinal Serological Surveillance for COVID-19 Antibodies after Infection and Vaccination. | Microbiology spectrum | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36127984 | Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review. | Cureus | 2022 | name in title: Ad26.COV2.S |
| PMID 36146992 | A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine. | The journal of the Royal College of Physicians of Edinburgh | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36185943 | Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination. | Cureus | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36212671 | Acute-onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases. | The Egyptian journal of neurology, psychiatry and neurosurgery | 2022 | name in title: Ad26.COV2.S |
| PMID 36219526 | Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literature. | Dermatologic therapy | 2022 | name in title: Ad26.COV2.S |
| PMID 36267879 | Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery. | Frontiers in neurology | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36274082 | COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study. | Clinical drug investigation | 2022 | name in abstract: Jcovden |
| PMID 36287798 | Preliminary Analysis of the Effects of Ad26.COV2.S Vaccination on CT Findings and High Intensive Care Admission Rates of COVID-19 Patients. | Tomography (Ann Arbor, Mich.) | 2022 | name in title: Ad26.COV2.S |
| PMID 36309347 | The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups. | JMIR formative research | 2022 | cited by trial NCT04832932 |
| PMID 36311588 | Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on. | Frontiers in public health | 2022 | name in abstract: Ad26.COV2.S |
| PMID 36357712 | Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. | Nature microbiology | 2022 | cited by trial NCT04505722 |
| PMID 36423045 | Portal Vein and Mesenteric Artery Thrombosis Following the Administration of an Ad26.COV2-S Vaccine-First Case from Romania: A Case Report. | Vaccines | 2022 | name in title: Ad26.COV2.S |
| PMID 36655834 | [Possible vaccine-induced immune thrombotic thrombocytopenia in a patient with diabetes and chronic kidney disease or random association?]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia | 2022 | name in abstract: Ad26.COV2.S |
| PMID 38620988 | COVID-19 vaccine (Ad26.COV2.S), an unlikely culprit of portal vein thrombosis in a middle-aged man. | Thrombosis update | 2022 | name in title: Ad26.COV2.S |
| PMID 33440088 | Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. | The New England journal of medicine | 2021 | cited by trial NCT04436276 |
| PMID 33524316 | SARS-CoV-2 evolution and vaccines: cause for concern? | The Lancet. Respiratory medicine | 2021 | cited by trial NCT04505722 |
| PMID 33704352 | Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. | JAMA | 2021 | cited by trial NCT04436276 |
| PMID 33852795 | Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. | The New England journal of medicine | 2021 | name in title: Ad26.COV2.S |
| PMID 33882225 | Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. | The New England journal of medicine | 2021 | cited by trial NCT04505722 |
| PMID 33929487 | US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. | JAMA | 2021 | name in title: Ad26.COV2.S |
| PMID 33980419 | Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination. | The American journal of emergency medicine | 2021 | name in title: Ad26.COV2.S |
| PMID 33989437 | Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination. | American journal of hematology | 2021 | name in title: Ad26.COV2.S |
| PMID 33997209 | Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine. | JAAD case reports | 2021 | name in title: Ad26.COV2.S |
| PMID 34056055 | A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine. | JAAD case reports | 2021 | name in title: Ad26.COV2.S |
| PMID 34057234 | Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. | American journal of hematology | 2021 | name in title: Ad26.COV2.S |
| PMID 34096082 | Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. | American journal of hematology | 2021 | name in title: Ad26.COV2.S |
| PMID 34107529 | Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. | Nature | 2021 | name in title: Ad26.COV2.S |
| PMID 34175640 | Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34226070 | Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination. | Annals of emergency medicine | 2021 | name in title: Ad26.COV2.S |
| PMID 34337124 | Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination. | JAAD case reports | 2021 | name in title: Ad26.COV2.S |
| PMID 34360156 | COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects. | International journal of environmental research and public health | 2021 | cited by trial NCT04834869 |
| PMID 34375510 | Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites. | Journal of thrombosis and haemostasis : JTH | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34408937 | A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. | Cureus | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34447646 | Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine. | Cureus | 2021 | name in title: Ad26.COV2.S |
| PMID 34452028 | A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization. | Vaccines | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34469919 | Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine. | American journal of therapeutics | 2021 | name in title: Ad26.COV2.S |
| PMID 34477089 | [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19]. | Ugeskrift for laeger | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34496194 | Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. | The New England journal of medicine | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34516272 | Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. | Annals of internal medicine | 2021 | name in title: Ad26.COV2.S |
| PMID 34547677 | Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021 | name in title: Ad26.COV2.S |
| PMID 34581763 | Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. | JAMA neurology | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34587255 | VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis. | Blood advances | 2021 | name in title: Ad26.COV2.S |
| PMID 34622311 | Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study. | Rheumatology international | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34659839 | Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male. | Case reports in critical care | 2021 | name in title: Ad26.COV2.S |
| PMID 34691071 | Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol. | Frontiers in immunology | 2021 | name in title: Ad26.COV2.S |
| PMID 34703690 | A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination. | Cureus | 2021 | name in title: Ad26.COV2.S |
| PMID 34790811 | An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine-a case report. | Annals of translational medicine | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34824596 | A plain language summary of how well the single-dose Janssen vaccine works and how safe it is. | Future virology | 2021 | cited by trial NCT04505722 |
| PMID 34863358 | Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. | Lancet (London, England) | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34887867 | Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. | Frontiers in immunology | 2021 | name in abstract: Ad26.COV2.S |
| PMID 34889361 | Clots in unusual places: lots of stress, limited data, critical decisions. | Hematology. American Society of Hematology. Education Program | 2021 | name in abstract: Ad26.COV2.S |
| PMID 35130405 | New-onset cutaneous lupus erythematosus after the COVID-19 vaccine. | Dermatology online journal | 2021 | name in abstract: JNJ-78436735 |
| PMID 33083026 | Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. | NPJ vaccines | 2020 | cited by trial NCT04436276 |